Bard Associates reports 336,007 shares in Intellinetics (INLX) — 7.5% stake
Rhea-AI Filing Summary
Intellinetics Inc reports a Schedule 13G filing showing Bard Associates, Inc. beneficially owns 336,007 shares of Common Stock, representing 7.5%.
The filing breaks down voting and dispositive power: 19,650 shares of sole voting and dispositive power and 316,357 shares of shared dispositive power. The filing is signed by Michael Demaray, President, dated 05/14/2026.
Positive
- None.
Negative
- None.
Insights
Bard Associates reports a non‑control stake of 336,007 shares (7.5%), disclosing voting and dispositive splits.
The filing lists 19,650 shares with sole voting/dispositive power and 316,357 shares with shared dispositive power. This indicates a significant passive stake without stated intent to influence control.
Watch subsequent filings for changes in reported percentages or statements of intent; timing of any disclosure is not included in the excerpt.